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OBJECTIVE — To determine whether increased daily physical activity improves mitochon-
drial function and/or lipid oxidation in type 2 diabetes.
RESEARCH DESIGN AND METHODS — Volunteers with (n  10) and without (n 
10) type 2 diabetes were matched for habitual physical activity, age, sex, and weight. Basal and
maximalmitochondrialactivity,physicalactivity,andrestingsubstrateoxidationweremeasured
at baseline and after 2 and 8 weeks of increased physical activity.
RESULTS — Baseline physical activity (6,450  851 vs. 7,638  741 steps/day), basal ATP
use (12  1 vs. 12  1 mol   ml
1   min
1), phosphocreatine recovery from exercise (31  5
vs.293s),andbasallipidoxidation(0.570.07vs.0.650.06mg kgbodywt
1 min
1)
were similar in people with and without type 2 diabetes. There was a signiﬁcant increase in
physical activity after 8 weeks (12,322  1,979 vs. 9,187  1,159 steps/day, respectively).
Following increased physical activity, there were no changes in basal ATP use or phosphocre-
atine recovery after exercise in either group. Basal lipid oxidation increased after 8 weeks of
increased physical activity in people with type 2 diabetes (0.79  0.08 mg   kg
1   min
1) but
not people without (0.68  0.13 mg   kg body wt
1   min
1).
CONCLUSIONS — Resting and maximal ATP turnover are not impaired in people with
well-controlled type 2 diabetes compared with control subjects matched for physical activity as
well as age and weight. Increased unsupervised daily physical activity is sustainable and im-
proves lipid oxidation independent of change in mitochondrial activity in people with type 2
diabetes.
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T
he potential role of the mitochon-
dria in the development of insulin
resistance and type 2 diabetes has
recently attracted much interest. Muscle
biopsies taken from people with type 2
diabetes demonstrate smaller mitochon-
dria and lower activities of oxidative en-
zymes compared with those of lean
individuals without diabetes (1). Insulin-
resistant people with a family history of
diabetes have reduced basal mitochon-
drial activity in skeletal muscle compared
with insulin-sensitive individuals (2).
These observations, in combination with
others (3–6), raise the possibility that mi-
tochondrial defects could underlie type 2
diabetes. Defects in oxidative function
could possibly help explain the impaired
fatty acid oxidation (7) and elevated in-
tramyocellular lipid (IMCL) (8) charac-
teristic of impaired insulin action and
type2diabetes.Theelevatedintramuscu-
lar lipid may affect insulin signaling in
skeletal muscle (5), exacerbating insulin
resistance.
However, other studies have not ob-
served abnormalities in basal mitochon-
drial activity in skeletal muscle of people
with type 2 diabetes (9). Recent biopsy
work has also shown that differences in
oxidative enzymes between people with
and without type 2 diabetes disappear
whencorrectedformitochondrialdensity
(10). These data raise the possibility that
type 2 diabetes is associated with normal
mitochondrial function but that the mito-
chondrial capacity is reduced. This is an
important differentiation, as it holds im-
plications for the therapeutic approach to
type 2 diabetes.
People with type 2 diabetes are more
sedentary than those without diabetes
(11). It is clear that reversing this seden-
tary lifestyle with physical activity and/or
exercisecanproducesigniﬁcantimprove-
ments in long-term glucose control (12).
These beneﬁts could be mediated, at least
inpart,bychangesinmitochondrialfunc-
tion (13). In people with type 2 diabetes,
moderate-intensity exercise combined
with moderate weight loss produced a
signiﬁcant improvement in insulin sensi-
tivity and mitochondrial density (14).
However, such moderate intensity exer-
cise programs are difﬁcult to implement
and usually require close supervision. In
contrast, unsupervised walking has been
shown to produce signiﬁcant improve-
ments in long-term glucose control and is
a sustainable behavior over long periods
of time (2 years) (15). Little is known
about how low-intensity physical activity
interventions such as walking inﬂuence
muscle metabolism in people with type 2
diabetes.
This study was designed to 1) deter-
mine whether there are differences in
basal and stimulated mitochondrial activ-
ity in people with type 2 diabetes com-
pared with physical activity–matched
control subjects and 2) establish whether
an increase in daily physical activity is
associated with changes in mitochon-
drial ATP turnover and changes in lipid
oxidation.
RESEARCH DESIGN AND
METHODS
Subject information and initial
testing
Sedentary people with type 2 diabetes
(2 years duration, A1C 7.5%, stable
control on either diet or diet plus sulfo-
nylurea and/or metformin) (n  10) and
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matched people without type 2 diabetes
(n  10) were recruited. Volunteers with
heart, liver, kidney, or diabetic foot dis-
ease or those undertaking a physical
activity program were excluded. Partici-
pantswereassessedbeforeandafter2and
8 weeks of increased physical activity. At
each time point, physical activity, resting
substrate oxidation, fasting plasma glu-
cose, and A1C were assessed. Basal and
maximal ATP use and IMCL were quanti-
tated using magnetic resonance tech-
niques. For all metabolic evaluations,
participants were transported to the mag-
netic resonance facility by taxi and data
were collected in the fasted state. Partici-
pants provided informed consent to join
the study, and the study was approved by
the local research ethics committee.
Magnetic resonance acquisition
Magnetic resonance data were acquired
using a 3T Achieva scanner (Philips, Best,
the Netherlands) with an in-built body
coil used for imaging, a 14-cm diameter
surfacecoilforphosphorusspectroscopy,
anda10-cmdiameterpairofﬂexiblecoils
(Philips) for proton spectroscopy.
Resting ATP ﬂux
This technique has previously been de-
scribed in nontechnical terms (16). In
brief, a saturation transfer sequence was
usedtomeasuretransferofmagnetization
between -ATP and inorganic phosphate
(Pi) (17). The steady-state magnetization
of Pi was measured during selective irra-
diationof-ATP(Mz)andcomparedwith
the equilibrium Pi magnetization with the
irradiation placed symmetrically down-
ﬁeld from the Pi frequency (TR  25 s,
bandwidth  3,000 Hz, 2,048 points, 16
averages) (Mo). The fractional reduction
of Pi magnetization upon saturation of
-ATP, (Mo  Mz)/Mo, was used to calcu-
late the pseudo–ﬁrst order rate constant
using the Forsen-Hoffman equation (18).
T1* was measured using an inversion re-
covery experiment (1  180
o  2 
90°  acquire, TR  25 s, four averages),
while saturation of -ATP was performed
during the delay times 1 and 2. Broad-
band proton decoupling was used. Eight
variable 2 time delays were used ranging
from 635 to 9,035 ms. The intraday vari-
abilityofthemethodis6.5%andinterday
variation 8.0%.
Maximal ATP generation
Plantar ﬂexion exercise at 30% of the
maximumvoluntarycontractionwasper-
formed in the magnetic resonance imag-
ingscanneronacustom-builtdevice.The
studyprotocolconsistedof3minofplan-
tar ﬂexion at 2 Hz and 3 min of rest,
changing pH levels as little as possible
(19). Phosphorus spectra were collected
at 10-s intervals throughout exercise
(NS  2, bandwidth  3,000 Hz, 2,048
points, broadband decoupling, and
NOE).
IMCL
Proton magnetic resonance spectroscopy
was acquired using a localized PRESS se-
quence (voxel size 15 	 15 	 20 mm) in
soleus with water suppression (TR/TE/
NSA  3,000 ms/37 ms/32,2048 sam-
ples, bandwidth 2,000 Hz). Sixteen
unsuppressed averages were collected for
reference.
Quantitation of spectra
Analysisofallspectrawasperformedwith
jMRUI (version 3.0) (20) using AMARES
(21),withcustompriorknowledge.Phos-
phcreatine(PCr)concentrationswerecal-
culated by measuring PCr relative to

-ATP,correctingformagneticsaturation
and assuming a resting (ATP) of 8.2
mmol/l (19). Maximal ATP production
wasassessedfrompostexercisePCrkinet-
ics (19). Proton spectra were analyzed for
IMCL and expressed relative to the water
reference peak.
Physical activity
Physical activity was assessed over 3 days
using a validated multisensor armband
(22)(SenseWear;Bodymedia,Pittsburgh,
PA). Physical activity goals were set, with
participants targeting 45 min of extra
walking per day, and the beneﬁts to glu-
cose control (diabetes group) and long-
term well-being (control group)
discussed. Participants were also pro-
vided with a pedometer, they recorded
the pedometer reading, and they received
periodic phone calls from the research
team.
Indirect calorimetery
Expired gases were collected from a con-
stant-ﬂow hood calorimeter (Deltatrac;
Datex Ohmeda, Hertfordsire, U.K.) over
30 min. Substrate oxidation rates and en-
ergy expenditure were calculated from
oxygen consumption and carbon dioxide
production values using stoichiometric
equations (23).
Whole-blood glucose and plasma
insulin
Whole-blood glucose was measured (YSI
glucose analyzer; YSI, Yellow Springs,
OH). Plasma insulin was measured using
an enzyme-linked immunosorbent assay
kit (DAKO, Ely, U.K.). A1C was mea-
sured using high-performance liquid
chromatography (TOSOH, Tokyo, Japan).
Statistical analysis
Statistical calculations were performed
using SPSS version 11 (SPSS, Chicago,
IL). Two-way ANOVA (time and treat-
ment) was used to assess metabolic and
physiological differences between
groups. Statistical signiﬁcance was ac-
cepted at P  0.05. Data are presented as
means  SE of the mean, unless other-
wise stated.
RESULTS
Baseline group description
The characteristics of the type 2 diabetes
and control groups are given in Table 1.
Groups were matched for age, sex, and
weight. The diabetic group was shorter
Table 1—Baseline physical and metabolic characteristics of subjects
Type 2 diabetic subjects Control subjects
Age (years) 59  25 6  2
Weight (kg) 91  48 8  4
BMI 33  1* 30  1
Energy expenditure (kcal/day) 2,319  112 2,460  146
Total steps/day 6,450  851 7,638  741
Systolic blood pressure (mmHg) 143  2* 134  5
Diastolic blood pressure (mmHg) 87  28 5  3
A1C (%) 6.7  0.3† 5.7  0.1
Fasting glucose (mmol/l) 7.1  0.4† 5.5  0.2
Insulin (m/l) 13.9  3.5† 7.6  1.5
Data are means  SE. *Signiﬁcantly different from control subjects (P  0.05). †Signiﬁcantly different from
control subjects (P  0.01).
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higher BMI. Habitual physical activity
was similarly low in both groups. Partici-
pants with type 2 diabetes had good glu-
cose control, demonstrated by a mean
A1C of 6.7  0.3% and a fasting whole-
blood glucose concentration of 7.1  0.4
mmol/l.
Physical activity
The physical activity monitors showed
thatbothgroupshadlowbaselineactivity
levels. There was no signiﬁcant difference
in the number of steps taken per day be-
tween the diabetes and control groups at
baseline (Fig. 1). Following counseling,
bothgroupsdemonstratedasustainedin-
crease in the number of steps taken per
day (P  0.05, Fig. 1). At 8 weeks, both
groups undertook more steps than base-
line; however, the control group had re-
duced the number of steps from the
2-week point (P  0.05) (Fig. 1).
Resting skeletal muscle metabolites
Skeletal muscle metabolites were similar
betweenthetwogroups(Table2).Resting
skeletal muscle ADP concentrations were
similar between people with or without
diabetes and did not change after 2 or 8
weeks of increased physical activity (Ta-
ble 2). There was no difference in resting
skeletal muscle pH between people with
and without diabetes, and this was not
inﬂuenced by 2 and 8 weeks of increased
physical activity (Table 2). Similarly, the
ratio of IMCL to water was comparable
between people with and without diabe-
tes at baseline and also did not change
after 2 and 8 weeks of increased physical
activity (Table 2).
Mitochondrial activity
The type 2 diabetic and control groups
showed similar basal and maximal ATP
turnover rates (Table 3). There was no
relationshipbetweenbasalandmaximal
ATP turnover (R
2  0.194, P  0.05).
Both basal and maximal ATP turnover
remained constant following 2 or 8
weeks of increased physical activity in
either the type 2 diabetes or control
group (Table 3). End-exercise ADP and
PCr use during exercise were similar
(Table 3), ensuring that the recovery
modeling of phosphocreatine was com-
pleted from similar metabolic starting
points.
Indirect calorimetery
People with and without type 2 diabetes
showed similar levels of carbohydrate
(2.82  0.19 vs. 2.61  0.17 mg   kg
body wt
1   min
1) and lipid oxidation
(Fig. 1). There were no changes in basal
energyexpenditureatanytimepoint.Fol-
lowing 8 weeks of increased physical ac-
tivity, the diabetes group showed an
Figure 1—Number of steps walked, basal ATP ﬂux, and basal lipid oxidation by people with (f)
andwithout(F)type2diabetesatbaselineandafter2and8weeksofincreasedphysicalactivity.
†Signiﬁcantly different from baseline. ‡Signiﬁcantly different from 2 weeks (P  0.05).
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and a decrease in rate of carbohydrate ox-
idation (to 2.26  0.022 mg   kg body
wt
1   min
1).
Plasma glucose, insulin, and A1C
People with type 2 diabetes had higher
A1C (P  0.01, Table 2) and fasting
plasma glucose levels (P  0.01) (Table
2). Insulin sensitivity, as assessed using
homeostasis model assessment, was
lower in people with type 2 diabetes than
in control subjects (P  0.05) (Table 2).
In the type 2 diabetes group, there was a
nonsigniﬁcant trend toward lower fasting
plasma glucose (P  0.08) (Table 2).
Anthropometric measurements
There were no differences in weight be-
tween people with and without type 2 di-
abetes (Table 1). There was no change in
weightinthetype2diabetesgroupafter2
weeks, although after 8 weeks there was a
signiﬁcant decrease relative to both base-
line and 2 weeks (P  0.05) (Table 2).
Control subjects showed no change in
weight after 2 or 8 weeks of increased
physical activity (Table 2).
CONCLUSIONS — We observed no
abnormality in mitochondrial function in
people with well-controlled type 2 diabe-
tes compared with physical activity–,
age-, and weight-matched control sub-
jects. There was no relationship between
basal (fasted) and maximal (recovery
from exercise) ATP synthesis, suggesting
that the factors inﬂuencing basal and
maximal ATP synthesis are different. The
physical activity intervention markedly
increased the number of steps taken per
dayduringthe8-weekintervention.Fast-
ing lipid oxidation was increased, but
there was no change in ATP turnover or
maximal ATP production.
The observation of no abnormality in
basal ATP ﬂux contrasts with recent stud-
ies. The seminal study (2) indicating the
possible importance of mitochondrial
function in development of type 2 diabe-
tes observed basal ATP ﬂux in extreme
phenotypes of insulin sensitivity. From
150 screened subjects, the most and least
insulin-sensitive people underwent as-
sessment of basal ATP ﬂux and IMCL us-
ing magnetic resonance techniques. The
14 least insulin-sensitive subjects (with a
familyhistoryofdiabetes)hadlowerbasal
ATP ﬂux and higher intramuscular lipid
levels than the 10 most insulin-sensitive
people. It was suggested that impaired
mitochondrial function reduces the abil-
ity to oxidize lipids, with accumulation of
intramuscular lipid impeding insulin sig-
naling (5), forming a pathway from im-
paired mitochondrial function to the
development of type 2 diabetes. A further
study (3) demonstrated impaired ATP
ﬂux in people with type 2 diabetes, but
the control subjects were unmatched for
habitual physical activity. The present
data agree with a recent study (9) report-
ing no difference in basal ATP use be-
tween age-, weight-, and physical
activity–matched subjects with and with-
outtype2diabetesusingsaturationtrans-
fer magnetic resonance. This study was
only able to demonstrate differences in
ATP ﬂux in people with type 2 diabetes
under insulin-stimulated conditions. The
observation of no abnormality in basal
ATP ﬂux in diabetes implies that abnor-
mal basal mitochondrial function is un-
likely to be a primary causative factor in
type 2 diabetes.
In contrast to basal ATP synthesis
rates, which are primarily inﬂuenced by
steady-state energy demand, the recovery
of PCr from exercise is a robust measure
of maximal oxidative ATP turnover (19).
This also reﬂects the recovery from mus-
cular activity that happens frequently
throughout the waking day, and any ab-
normality could bring about marked dif-
ferences in muscle metabolism that may
be associated with type 2 diabetes. The
present data show no differences in the
recovery of PCr from exercise between
people with and without type 2 diabetes
when controlled for habitual physical ac-
tivity,weight,andage.Toourknowledge,
the present study is the ﬁrst report to in-
clude both measures of basal and maxi-
mal ATP turnover in people with or
without diabetes. No correlation was
found between the basal and maximal
ATP turnover rates. The lack of relation-
ship between basal and maximal ATP
turnover supports the concept that ATP
turnover in these tests is determined by
different factors. In the fasted, nonexer-
cise state, the level of insulin-stimulated
glucose uptake is likely to dominate re-
quirementforATPsynthesis.Thissugges-
tionisbasedonstudiesthatshowarobust
relationship between ATP synthesis and
insulin-stimulatedglucoseuptakeinskel-
etal muscle (9). In the postexercise stim-
ulated state, the ability to supply and use
oxygen is likely to dominate the rate of
ATP turnover. The lack of correlation be-
tween the basal and maximal measures of
ATP synthesis highlights the importance
of examining separately these differing
states.
Table2—Magneticresonancespectroscopymeasurementsonmuscleinpeoplewithandwithouttype2diabetesbeforeandafter2and8weeks
of increased physical activity
Resting data
Type 2 diabetic subjects Control subjects
Baseline 2 weeks 8 weeks Baseline 2 weeks 8 weeks
ADP (mol/l) 9.54  0.17 9.75  0.13 9.47  0.12 9.38  0.18 9.43  0.13 9.33  0.12
pH 7.04  0.01 7.05  0.01 7.04  0.01 7.03  0.01 7.03  0.01 7.03  0.01
IMCL (relative to H2O) 0.032  0.006 0.035  0.009 0.029  0.003 0.037  0.005 0.037  0.004 0.038  0.005
End-exercise data
End-exercise ADP (mol/l) 33.3  5.1 33.4  4.9 36.8  4.8 34.8  3.7 33.9  4.7 38.9  3.8
PCr use during exercise (% resting) 25  42 7  52 9  42 7  32 5  32 9  3
Glucose control
A1C (%) 6.7  0.3* 6.7  0.3* 6.6  0.2* 5.7  0.1 5.7  0.1 5.6  0.1
Fasting glucose (mmol/l) 7.1  0.4* 7.0  0.4* 6.5  0.5 5.5  0.2 5.7  0.2 5.5  0.2
Insulin (mu/l) 13.9  3.5 13.1  2.2 11.7  2.3 8.1  1.4 10.2  3.0 7.6  1.5
Homeostasis model assessment 4.4  1.1* 4.2  0.8* 3.4  0.8* 2.0  0.4 2.1  0.4 1.9  0.4
Data are means  SE. *Signiﬁcantly different from people without diabetes (P  0.05).
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malATPturnovertobereducedinpeople
with type 2 diabetes compared with a
BMI-matched control group. However,
this study did not objectively control for
differences in habitual physical activity, a
factor that can inﬂuence mitochondrial
function(13).Peoplewithtype2diabetes
tend to be less physically active than peo-
ple without diabetes (11). Indeed, the re-
ported PCr recovery data postexercise of
people with type 2 diabetes (3) are com-
parable with both the type 2 diabetes and
control groups in the present study, rais-
ing the likelihood that the differences in
maximal ATP turnover may lay in differ-
ences in habitual physical activity. Recent
support has also been given to the idea
that type 2 diabetes is not necessarily as-
sociated with impaired mitochondrial
functionbutmayreﬂectdifferencesinmi-
tochondrial volume. Direct analyses of
mitochondria from biopsies taken from
peoplewithtype2diabetesshowthatany
apparent defect in mitochondrial ATP
production disappears when corrected
for mitochondrial density (10). The re-
duced oxidative capacity accompanying
type 2 diabetes may be the result of a de-
conditioning phenomenon (24).
Thepresentstudyshowsthatwalking
an extra 45 min per day over an 8-week
period is an insufﬁcient stimulus to in-
duce detectable mitochondrial biogene-
sis. The physical activity was deliberately
chosen to be of low intensity, as walking
has been shown to be achievable and sus-
tainable by people with type 2 diabetes
(15,25). More intensive and prolonged
physicalactivityanddietdoeschangemi-
tochondrial density and aerobic capacity
(14). These changes correlate well with
improvements in long-term glucose con-
trol and fasting insulin sensitivity. Other
biopsy data suggest that the beneﬁcial ef-
fect of exercise and moderate weight loss
upon mitochondrial density is modest
(26). However, the in vitro function of
mitochondria is improved, with a dispro-
portionate increase in electron transfer
chain activity following intervention. The
improvements of mitochondrial function
accompanying exercise are not replicated
by weight loss alone (27), stressing the
importance of exercise in modifying oxi-
dative capacity and maintaining meta-
bolic ﬂexibility. Further work is required
to deﬁne the long-term effects of practi-
cally sustainable physical activity on mi-
tochondrial function in muscle.
In type 2 diabetes changes in mito-
chondrial capacity are intertwined with
changes in lipid oxidation (7). The
present data demonstrate physical activi-
ty–induced enhancement of resting lipid
oxidation, independent of intramuscular
lipid levels. Type 2 diabetes is character-
ized by both abnormal lipid storage and
oxidation, with glucose control com-
monlyreportedtobenegativelyrelatedto
intramuscular lipid content (2,8,28) via
an effect on insulin action (5). Walking
for an extra 45 min each day increases
skeletal muscle mRNA expression of
genes implicated in glucose and lipid me-
tabolism (25). The cumulative effect of a
sustained increase in lipid oxidation and
decrease in IMCL would be expected to
improve blood glucose control (15). The
effects of increased physical activity upon
circulating triglyceride turnover, and the
consequential inﬂuence upon insulin ac-
tion, remain to be determined.
An important aspect of this study is
thatpeoplewithtype2diabeteswereable
tosustainamorephysicallyactivelifestyle
without supervision, and this would be
expected to inﬂuence metabolic risk and
glucose control (29). The study was not
powered to detect changes in glucose
control in the basal state, as this was not a
primary objective. However, measures of
glucose control were lower following in-
creased physical activity. Other dynamic
testingmethodsmayhavebeenmoresen-
sitivetochangesininsulinsensitivitythan
homeostasis model assessment. These
data are in line with larger, better pow-
ered studies of walking interventions
(12).Nochangeinserumtriglyceridesoc-
curred in either group (data not shown).
It is also possible that the various motiva-
tions for taking part in this study pro-
duced differences in the physical activity
behavior. It is notable that the diabetic
individuals sustained the level of physical
activity better than the nondiabetic con-
trol group. The challenge ahead is to bet-
terunderstandhowwecanengagepeople
with type 2 diabetes in reducing seden-
tary periods as well as to deﬁne how the
underlying physiological mechanisms
produce these beneﬁts.
The magnetic resonance methods ap-
plied here, and previously (2,3,9,17), are
not without limitation. As the mitochon-
driaarenotisolated,ATPproductionmay
be limited by external factors, such as the
supply of oxygen or ATP demand. How-
ever, with these limitations noted, it is
clear that these noninvasive techniques
provide a patient-friendly methodology
that can be applied serially and comple-
ments more detailed in vitro techniques.
In summary, resting and maximal
ATP turnover are not impaired in people
with well-controlled type 2 diabetes,
when compared with control subjects
matched for physical activity as well as
age and weight. Increased daily physical
activity in the form of walking is sustain-
able and improves lipid oxidation inde-
pendent of mitochondrial activity in
people with type 2 diabetes.
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